CMET-40. LONG-LASTING RESPONSE IN SPINAL METASTASES FROM ALK REARRANGED NON-SMALL-CELL LUNG CANCER TREATED WITH DIFFERENT ALK INHIBITORS

INTRODUCTION: About 40% of ALK-rearranged NSCLC patients develop brain metastases (BM), while leptomeningeal metastases (LM) occur in 5% of patients, and spinal intramedullary metastases in < 1%. Few data are available regarding the efficacy of ALK inhibitors in neoplastic spinal disease from NSC...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuro Oncol
Autori principali: Pellerino, Alessia, Rudà, Roberta, Franchino, Federica, Marchese, Giulia, Bruno, Francesco, Mo, Francesca, Soffietti, Riccardo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Abstracts
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216985/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.250
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi